MacVittie, T J <br/><br/>
Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.  [electronic resource] 

 -  Blood  Feb 2000 
 - 837-45 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Cell Count--drug effects<br/>Blood Transfusion<br/>Bone Marrow Diseases--etiology<br/>Cell Lineage<br/>Colony-Forming Units Assay<br/>Dose-Response Relationship, Radiation<br/>Drug Design<br/>Drug Evaluation, Preclinical<br/>Granulocyte Colony-Stimulating Factor<br/>Hematopoiesis--drug effects<br/>Hematopoietic Cell Growth Factors--chemistry<br/>Interleukin-3<br/>Macaca mulatta<br/>Male<br/>Neutropenia--drug therapy<br/>Protein Engineering<br/>Radiation Injuries, Experimental--drug therapy<br/>Receptors, Granulocyte Colony-Stimulating Factor--agonists<br/>Receptors, Interleukin-3--agonists<br/>Recombinant Fusion Proteins<br/>Recombinant Proteins<br/>Thrombocytopenia--drug therapy<br/>Whole-Body Irradiation--adverse effects